• Inhibikase Therapeutics Inc. (IKT) Q1 2026 Earnings: Narrowed Loss Beats Estimates as Pipeline Progress Continues dars.gov.et Wed, 08 Jul 2026 02:48:30 GMT
• Inhibikase Grants Equity Awards to New Employees Under Nasdaq Rule MyChesCo Mon, 06 Jul 2026 19:36:58 GMT
• Inhibikase Therapeutics Inc (NASDAQ: IKT) Share Price, IKT Stock News, IKT Share Price & Updates Kalkine Thu, 02 Jul 2026 23:00:00 GMT
• Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Thu, 02 Jul 2026 20:01:00 GMT
• Inhibikase awards stock options to 7 new hires under inducement plan Stock Titan Thu, 02 Jul 2026 20:01:00 GMT
• inhibikase therapeutics inc (nasdaq: ikt) share price, ikt stock news, ikt share price & updates Kalkine Wed, 01 Jul 2026 20:00:00 GMT
• Inhibikase Therapeutics (IKT) director granted 155,000 options at $1.91 strike Stock Titan Tue, 30 Jun 2026 20:05:54 GMT
• Director at Inhibikase (NASDAQ: IKT) receives 155K stock options grant Stock Titan Tue, 30 Jun 2026 20:05:54 GMT
• Inhibikase (IKT) director receives 155,000 stock options at $1.91 strike price Stock Titan Tue, 30 Jun 2026 20:05:54 GMT
• Inhibikase (IKT) director awarded 155,000 stock options at $1.91 exercise price Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Inhibikase (IKT) director Dennis Berman granted options for 155,000 shares Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Inhibikase Shareholders Approve Governance and Compensation Changes TipRanks Mon, 29 Jun 2026 10:34:32 GMT
• Inhibikase (NASDAQ: IKT) investors back 3M-share plan boost and officer protections Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Inhibikase Therapeutics, Inc.(NasdaqCM:IKT) dropped from Russell 3000 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 01:27:25 GMT
• enterprise value to ebitda forward of inhibikase therapeutics, inc. – nasdaq:ikt TradingView Sun, 28 Jun 2026 13:13:28 GMT
• Inhibikase Therapeutics, Inc.(NasdaqCM:IKT) dropped from Russell 2000 Growth Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Enterprise value to EBIT forward of Inhibikase Therapeutics, Inc. – NASDAQ:IKT TradingView Sat, 27 Jun 2026 11:19:55 GMT
• price to sales forward of inhibikase therapeutics, inc. – boats:ikt TradingView Sat, 27 Jun 2026 06:57:48 GMT
• price to book forward of inhibikase therapeutics, inc. – boats:ikt TradingView Sat, 27 Jun 2026 05:27:56 GMT
• Inhibikase Therapeutics, Inc. Actuals & Estimates (NASDAQ:IKT) TradingView Fri, 26 Jun 2026 08:55:22 GMT
• inhibikase therapeutics inc (ikt) institutional confidence TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• IKT Q1 2026 Earnings: Narrower-than-expected loss underscores disciplined spending - ROIC Trend Report dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 03:03:38 GMT
• Inhibikase Therapeutics (IKT) Holds Steady Near Support as Traders Await Catalyst - Bollinger Squeeze dars.gov.et Mon, 22 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) institutional confidence TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) risk assessment: volatility, financial risk & investment risk TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• cantor fitzgerald maintains inhibikase therapeutics(ikt.us) with buy rating, maintains target price $4 富途牛牛 Sat, 20 Jun 2026 09:23:05 GMT
• inhibikase therapeutics inc (ikt) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 01:49:08 GMT
• inhibikase therapeutics inc (ikt) institutional confidence TradingKey Fri, 19 Jun 2026 00:52:44 GMT
• inhibikase therapeutics inc (ikt) earnings forecast: future eps & revenue growth estimates TradingKey Fri, 19 Jun 2026 00:13:13 GMT
• inhibikase therapeutics inc (ikt) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 23:36:23 GMT
• inhibikase therapeutics inc (ikt) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 23:26:43 GMT
• inhibikase therapeutics inc (ikt) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 22:21:31 GMT
• Inhibikase Therapeutics Inc (IKT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 10:11:00 GMT
• inhibikase therapeutics inc (ikt) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 08:50:54 GMT
• inhibikase therapeutics inc (ikt) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 20:59:37 GMT
• inhibikase therapeutics q1 2026 earnings: narrower than expected loss amid pipeline progress - earnings expansion phase dars.gov.et Wed, 17 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• inhibikase therapeutics inc (ikt) institutional confidence TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) consolidates near $1.67 – key levels in focus - institutional flow picks dars.gov.et Sun, 14 Jun 2026 07:00:00 GMT
• ikt initiates coverage on oppenheimer -- rating set to outperfor GuruFocus Wed, 10 Jun 2026 21:15:37 GMT
• oppenheimer initiates inhibikase therapeutics at outperform marketscreener.com Wed, 10 Jun 2026 11:04:28 GMT
• inhibikase therapeutics initiated with an outperform at oppenheimer TipRanks Wed, 10 Jun 2026 07:00:00 GMT
• oppenheimer initiates inhibikase therapeutics(ikt.us) with buy rating, announces target price $5 富途牛牛 Wed, 10 Jun 2026 07:00:00 GMT
• lifesci capital maintains inhibikase therapeutics(ikt.us) with buy rating, maintains target price $5 富途牛牛 Tue, 09 Jun 2026 06:08:36 GMT
• inhibikase therapeutics (ikt) tests support zone after slight decline - factor valuation newsline.com Sun, 07 Jun 2026 23:42:14 GMT
• IKT Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress Continues - Guidance vs Actual dars.gov.et Fri, 05 Jun 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) edges higher, testing key resistance amid biotech sector uncertainty - cta positioning newsline.com Thu, 04 Jun 2026 07:00:00 GMT
• ikt technical analysis | trend, signals & chart patterns | inhibikase therapeutics inc (nasdaq:ikt) ChartMill Thu, 04 Jun 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) narrows lower: testing key support near $1.61 - chandelier stop dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• ikt q1 2026 earnings: narrow eps beat as clinical pipeline progress continues - quarterly financial update newsline.com Tue, 02 Jun 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) holds near support amid biotech sector headwinds - liquidity order flow newsline.com Fri, 29 May 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) recovers 3.5% as buyers defend key support level - rvol spike newsline.com Thu, 28 May 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) holds near support amid narrow trading range - composite profile dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) holds near support amid modest gains - nhnl ratio The Legal Advocate Tue, 26 May 2026 23:36:12 GMT
• inhibikase therapeutics: buy rating reiterated on advancing phase 3 pah program and robust ip, price target maintained at $8 TipRanks Tue, 26 May 2026 18:09:57 GMT
• h.c. wainwright maintains inhibikase therapeutics(ikt.us) with buy rating, maintains target price $8 Moomoo Tue, 26 May 2026 07:00:00 GMT
• Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Sup... Fidelity Mon, 25 May 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) dips 2.87% as stock approaches critical support at $1.61 - buyback factor newsline.com Mon, 25 May 2026 07:00:00 GMT
• inhibikase therapeutics q1 2026 earnings: narrower-than-expected loss but stock declines - earnings call highlights The Legal Advocate Sun, 24 May 2026 03:31:02 GMT
• inhibikase therapeutics q1 2026 earnings: narrower-than-expected loss but stock declines - slow growth warning dars.gov.et Sat, 23 May 2026 07:00:00 GMT
• ikt q1 2026 earnings: narrower loss beats estimates; stock slips on no revenue update - earnings recovery stocks The Legal Advocate Sat, 23 May 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) faces selling pressure as stock retreats to $1.69 - parabolic sar Newser Sat, 23 May 2026 02:32:16 GMT
• ikt sec filings - inhibikase therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Fri, 22 May 2026 17:41:52 GMT
• inhibikase therapeutics (ikt) q1 2026 earnings: narrowing losses as pipeline progress takes center stage - margin guidance newsline.com Fri, 22 May 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) faces selling pressure as stock retreats to $1.69 - obv breakout newsline.com Fri, 22 May 2026 07:00:00 GMT
• ikt sec filings - inhibikase therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Wed, 20 May 2026 08:28:25 GMT
• ikt stock chart | inhibikase therapeutics inc (nasdaq:ikt) ChartMill Wed, 20 May 2026 07:00:00 GMT
• cantor fitzgerald reiterates inhibikase stock overweight rating at $4 by investing.com Investing.com Nigeria Wed, 20 May 2026 04:35:42 GMT
• pulmonary arterial hypertension clinical trial pipeline gains momentum: 50+ companies lead the charge in pioneering new treatments... The Manila Times Tue, 19 May 2026 17:20:43 GMT
• cantor fitzgerald maintains inhibikase therapeutics(ikt.us) with buy rating, maintains target price $4 Moomoo Tue, 19 May 2026 12:34:00 GMT
• cantor fitzgerald reiterates inhibikase stock overweight rating at $4 by investing.com Investing.com Canada Tue, 19 May 2026 07:00:00 GMT
• ikt technical analysis | trend, signals & chart patterns | inhibikase therapeutics inc (nasdaq:ikt) ChartMill Tue, 19 May 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) stock analysis: falls -6.94%, watching $1.53 2026-05-18 - {涓偂鍓爣棰榼 Newser Mon, 18 May 2026 23:02:02 GMT
• bank of america securities reaffirms their buy rating on inhibikase therapeutics (ikt) The Globe and Mail Sat, 16 May 2026 07:00:00 GMT
• bofa securities maintains inhibikase therapeutics(ikt.us) with buy rating, maintains target price $6 Moomoo Sat, 16 May 2026 05:51:41 GMT
• adar1 reports 9.9% stake in inhibikase (nasdaq: ikt) via managed accounts Stock Titan Sat, 16 May 2026 00:16:26 GMT
• maxim group maintains inhibikase therapeutics(ikt.us) with buy rating, maintains target price $8 Moomoo Fri, 15 May 2026 13:35:00 GMT
• commodore capital (ikt) reports 14.05m shares equivalent, 9.9% cap Stock Titan Fri, 15 May 2026 07:00:00 GMT
• trails edge holds 8.06m inhibikase shares — trails edge (nasdaq: ikt) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• adar1 reports 9.9% stake in inhibikase (nasdaq: ikt) via managed accounts Stock Titan Fri, 15 May 2026 07:00:00 GMT
• perceptive advisors/perceptive life sciences disclose 8.9% holding in ikt (ikt) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• inhibikase therapeutics, inc. - common stock (nq: ikt FinancialContent Thu, 14 May 2026 12:39:51 GMT
• ikt technical analysis | trend, signals & chart patterns | inhibikase therapeutics inc (nasdaq:ikt) ChartMill Thu, 14 May 2026 07:00:00 GMT
• analyst flags high risk in inhibikase therapeutics stock, urges investors to review 2025 form 10-k risk factors TipRanks Thu, 14 May 2026 06:39:19 GMT
• analyst flags high risk in inhibikase therapeutics stock, urges investors to review 2025 form 10-k risk factors TipRanks Wed, 13 May 2026 07:00:00 GMT
• lifesci capital maintains inhibikase therapeutics(ikt.us) with buy rating, maintains target price $5 Moomoo Wed, 13 May 2026 07:00:00 GMT
• is inhibikase therapeutics (ikt) fairly valued after q1 2026 eps GuruFocus Tue, 12 May 2026 23:23:51 GMT
• inhibikase therapeutics releases first quarter 2026 financial results on may 12 geneonline.com Tue, 12 May 2026 21:04:18 GMT
• [10-q] inhibikase therapeutics, inc. quarterly earnings report Stock Titan Tue, 12 May 2026 20:39:07 GMT
• inhibikase therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 20:39:00 GMT
• [8-k] inhibikase therapeutics, inc. reports material event Stock Titan Tue, 12 May 2026 20:31:11 GMT
• Inhibikase Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Tue, 12 May 2026 07:00:00 GMT
• Inhibikase Advances PAH Drug with Global Phase 3 Trial Launch BriefGlance Tue, 12 May 2026 07:00:00 GMT
• phase 3 pah trial improve-pah spans 16 countries as orphan tag sought Stock Titan Tue, 12 May 2026 07:00:00 GMT
• inhibikase therapeutics, inc. 1q 2026: revenue $0 net income $(16.4)m, eps $(0.10) — 10-q summary TradingView Tue, 12 May 2026 07:00:00 GMT
• inhibikase therapeutics announces first quarter 2026 financial results and highlights recent activity Yahoo Finance Tue, 12 May 2026 07:00:00 GMT
• inhibikase therapeutics inc (nasdaq:ikt) reports q1 2026 results as phase 3 pah trial gains momentum ChartMill Tue, 12 May 2026 07:00:00 GMT
• inhibikase therapeutics ($ikt) releases q1 2026 earnings Quiver Quantitative Tue, 12 May 2026 07:00:00 GMT
• inhibikase advances ikt-001 into adaptive phase 3 trial for pulmonary arterial hypertension TipRanks Tue, 12 May 2026 07:00:00 GMT
• inhibikase (nasdaq: ikt) deepens q1 loss as pivotal pah trial advances globally Stock Titan Tue, 12 May 2026 07:00:00 GMT
• inhibikase (nasdaq: ikt) advances improve-pah as q1 2026 loss widens Stock Titan Tue, 12 May 2026 07:00:00 GMT
• what xxxs fundamentals reveal about its future (rallies) 2026-05-08 - ai powered stock picks Newser Fri, 08 May 2026 21:31:28 GMT
• inhibikase therapeutics inc expected to post a loss of 11 cents a share - earnings preview TradingView Fri, 08 May 2026 07:00:00 GMT
• ikt stock price, quote & chart | inhibikase therapeutics inc (nasdaq:ikt) ChartMill Thu, 07 May 2026 07:00:00 GMT
• ikt technical analysis | trend, signals & chart patterns | inhibikase therapeutics inc (nasdaq:ikt) ChartMill Thu, 07 May 2026 07:00:00 GMT
• how inhibikase therapeutics (ikt) is navigating logistics challenges | q4 2025: eps tops views - return on equity newsline.com Tue, 05 May 2026 07:00:00 GMT
• ikt technical analysis | trend, signals & chart patterns | inhibikase therapeutics inc (nasdaq:ikt) ChartMill Tue, 05 May 2026 07:00:00 GMT
• ikt inhibikase therapeutics beats q4 2025 loss estimates, shares post modest gains following earnings release. newsline.com Fri, 01 May 2026 07:00:00 GMT
• inhibikase therapeutics, inc. (nasdaq:ikt) given average recommendation of "buy" by brokerages MarketBeat Fri, 01 May 2026 07:00:00 GMT
• [def 14a] inhibikase therapeutics, inc. definitive proxy statement Stock Titan Thu, 30 Apr 2026 20:33:18 GMT
• inhibikase therapeutics (nasdaq: ikt) seeks 3m new plan shares and officer shield Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• inhibikase therapeutics notches 13.6% eps beat on narrower loss - saas earnings trends The Legal Advocate Wed, 29 Apr 2026 07:00:00 GMT
• is inhibikase therapeutics (ikt) stock reversing trend | inhibikase therapeutics notches 13.6% eps beat on narrower loss - graham ... Newser Wed, 29 Apr 2026 07:00:00 GMT
• inhibikase therapeutics sells 68.97m shares and pre-funded warrants at $1.45/share MSN Mon, 27 Apr 2026 18:15:21 GMT
• inhibikase therapeutics sells 68.97m shares and pre-funded warrants at $1.45/share MSN Sun, 26 Apr 2026 13:52:29 GMT
• inhibikase therapeutics sells 68.97m shares and pre-funded warrants at $1.45/share MSN Sat, 25 Apr 2026 22:12:42 GMT
• ikt financials: income statement, balance sheet & cash flow Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) asks shareholders to add 3m plan shares Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• inhibikase therapeutics (ikt) stock trading today (+7.65%) 2026-04-18 - change of character The Legal Advocate Sat, 18 Apr 2026 07:00:00 GMT
• what does insider activity suggest for inhibikase therapeutics (ikt) stock | price at $1.76, up 3.53% - rth profile newsline.com Mon, 13 Apr 2026 07:00:00 GMT
• macd signal: what is the moat score of inhibikase therapeutics inc - quarterly growth report & short-term high return ideas baoquankhu1.vn Fri, 10 Apr 2026 07:50:12 GMT
Inhibikase Therapeutics, Inc(NASDAQ:IKT) 
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease, and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a c-Abl protein kinase inhibitor for use in the treatment of P...
Share this website to your friends